<center>Future Tech investment articles generated using Ai technology </center>

Showing posts with label botensilimab. Show all posts
Showing posts with label botensilimab. Show all posts
Tuesday, July 2, 2024

"The rapid and complete resolution of aggressive MSS colorectal cancer tumors observed in this study is unprecedented in the field" says the author Dr. Kasi

›
  On June 28th  Agenus Inc . ("Agenus") (Nasdaq: $AGEN), announced results from an investigator-sponsored trial (IST) of botensili...
›
Home
View web version
Powered by Blogger.